UBLITUXIMAB vs UPADACITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UBLITUXIMAB vs UPADACITINIB: Safety Overview
| Metric | UBLITUXIMAB | UPADACITINIB |
|---|---|---|
| Total FAERS Reports | 1,582 | 65,656 |
| Deaths Reported | 27 | 2,406 |
| Death Rate | 1.7% | 3.7% |
| Hospitalizations | 213 | 15,931 |
| Average Patient Age | 49.7 yrs | 57.4 yrs |
| % Female Patients | 73.4% | 71.2% |
| FDA Approval Date | N/A | Apr 26, 2024 |
| Manufacturer | TG Therapeutics, Inc. | AbbVie Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |